ArticleJournal of nanobiotechnology2018

Vascular biosafety of commercial hydroxyapatite particles: discrepancy between blood compatibility assays and endothelial cell behavior.

Catarina Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.